Lin BioScience licenses cancer drug candidate from the University of Sydney
Taipei, Taiwan-based drug development startup Lin BioScience, Inc., recently announced an exclusive licensing agreement with Australia’s University of Sydney for a microtubule-targeting agent to treat brain cancers.
Read More